These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 20434888)

  • 1. Atypical antipsychotic drugs upregulate synapsin II in the prefrontal cortex of post-mortem samples obtained from patients with schizophrenia.
    Guest KA; Dyck BA; Shethwala S; Mishra RK
    Schizophr Res; 2010 Jul; 120(1-3):229-31. PubMed ID: 20434888
    [No Abstract]   [Full Text] [Related]  

  • 2. Medial prefrontal cortical synapsin II knock-down induces behavioral abnormalities in the rat: examining synapsin II in the pathophysiology of schizophrenia.
    Dyck BA; Beyaert MG; Ferro MA; Mishra RK
    Schizophr Res; 2011 Aug; 130(1-3):250-9. PubMed ID: 21689907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synapsin II gene expression in the dorsolateral prefrontal cortex of brain specimens from patients with schizophrenia and bipolar disorder: effect of lifetime intake of antipsychotic drugs.
    Tan ML; Dyck BA; Gabriele J; Daya RP; Thomas N; Sookram C; Basu D; Ferro MA; Chong VZ; Mishra RK
    Pharmacogenomics J; 2014 Feb; 14(1):63-9. PubMed ID: 23529008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced neuronal expression of insulin-degrading enzyme in the dorsolateral prefrontal cortex of patients with haloperidol-treated, chronic schizophrenia.
    Bernstein HG; Ernst T; Lendeckel U; Bukowska A; Ansorge S; Stauch R; Have ST; Steiner J; Dobrowolny H; Bogerts B
    J Psychiatr Res; 2009 Sep; 43(13):1095-105. PubMed ID: 19394958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral effects of non-viral mediated RNA interference of synapsin II in the medial prefrontal cortex of the rat.
    Dyck BA; Tan ML; Daya RP; Basu D; Sookram CD; Thomas N; Mishra RK
    Schizophr Res; 2012 May; 137(1-3):32-8. PubMed ID: 22341900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Change in expression of vesicular protein synapsin II by chronic treatment with D2 allosteric modulator PAOPA.
    Basu D; Tian Y; Hui P; Bhandari J; Johnson RL; Mishra RK
    Peptides; 2015 Apr; 66():58-62. PubMed ID: 25703303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficits in syntaxin 1 phosphorylation in schizophrenia prefrontal cortex.
    Castillo MA; Ghose S; Tamminga CA; Ulery-Reynolds PG
    Biol Psychiatry; 2010 Feb; 67(3):208-16. PubMed ID: 19748077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of synapsin III in the prefrontal cortex of individuals with schizophrenia.
    Porton B; Wetsel WC
    Schizophr Res; 2007 Aug; 94(1-3):366-70. PubMed ID: 17540541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic antipsychotic drug treatment induces long-lasting expression of fos and jun family genes and activator protein 1 complex in the rat prefrontal cortex.
    Kontkanen O; Lakso M; Wong G; Castrén E
    Neuropsychopharmacology; 2002 Aug; 27(2):152-62. PubMed ID: 12093589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex.
    Mirnics K; Middleton FA; Marquez A; Lewis DA; Levitt P
    Neuron; 2000 Oct; 28(1):53-67. PubMed ID: 11086983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lateral and medial hypofrontality in first-episode schizophrenia: functional activity in a medication-naive state and effects of short-term atypical antipsychotic treatment.
    Snitz BE; MacDonald A; Cohen JD; Cho RY; Becker T; Carter CS
    Am J Psychiatry; 2005 Dec; 162(12):2322-9. PubMed ID: 16330597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folding of the prefrontal cortex in schizophrenia: regional differences in gyrification.
    Palaniyappan L; Mallikarjun P; Joseph V; White TP; Liddle PF
    Biol Psychiatry; 2011 May; 69(10):974-9. PubMed ID: 21257157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low muscarinic receptor binding in prefrontal cortex from subjects with schizophrenia: a study of Brodmann's areas 8, 9, 10, and 46 and the effects of neuroleptic drug treatment.
    Crook JM; Tomaskovic-Crook E; Copolov DL; Dean B
    Am J Psychiatry; 2001 Jun; 158(6):918-25. PubMed ID: 11384900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for decreased DARPP-32 in the prefrontal cortex of patients with schizophrenia.
    Albert KA; Hemmings HC; Adamo AI; Potkin SG; Akbarian S; Sandman CA; Cotman CW; Bunney WE; Greengard P
    Arch Gen Psychiatry; 2002 Aug; 59(8):705-12. PubMed ID: 12150646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of metabolic hypofunction and neurochemical deficits after chronic intermittent exposure to phencyclidine: differential modulation by antipsychotic drugs.
    Cochran SM; Kennedy M; McKerchar CE; Steward LJ; Pratt JA; Morris BJ
    Neuropsychopharmacology; 2003 Feb; 28(2):265-75. PubMed ID: 12589379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. cDNA array reveals differential gene expression following chronic neuroleptic administration: implications of synapsin II in haloperidol treatment.
    Chong VZ; Young LT; Mishra RK
    J Neurochem; 2002 Sep; 82(6):1533-9. PubMed ID: 12354301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective increases in the cytokine, TNFalpha, in the prefrontal cortex of PCP-treated rats and human schizophrenic subjects: influence of antipsychotic drugs.
    Paterson GJ; Ohashi Y; Reynolds GP; Pratt JA; Morris BJ
    J Psychopharmacol; 2006 Sep; 20(5):636-42. PubMed ID: 16478754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-HT6 receptor binding sites in schizophrenia and following antipsychotic drug administration: autoradiographic studies with [125I]SB-258585.
    East SZ; Burnet PW; Leslie RA; Roberts JC; Harrison PJ
    Synapse; 2002 Sep; 45(3):191-9. PubMed ID: 12112397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decrease in olfactory and taste receptor expression in the dorsolateral prefrontal cortex in chronic schizophrenia.
    Ansoleaga B; Garcia-Esparcia P; Pinacho R; Haro JM; Ramos B; Ferrer I
    J Psychiatr Res; 2015 Jan; 60():109-16. PubMed ID: 25282281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-regulated 14-3-3β and 14-3-3ζ proteins in prefrontal cortex of subjects with schizophrenia: effect of psychotropic treatment.
    Rivero G; Gabilondo AM; García-Sevilla JA; La Harpe R; Morentín B; Meana JJ
    Schizophr Res; 2015 Feb; 161(2-3):446-51. PubMed ID: 25549848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.